Literature DB >> 12540653

Thrombolytic therapy in patients with submassive pulmonary embolism.

Rendell W Ashton, Craig E Daniels, Jay H Ryu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12540653     DOI： 10.1056/NEJM200301233480416

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

2.  [Therapeutic approaches to acute pulmonary embolism].

Authors:  A Reissig; C Kroegel
Journal:  Internist (Berl)       Date:  2004-05       Impact factor: 0.743

3.  Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial.

Authors:  Chen Wang; Zhenguo Zhai; Yuanhua Yang; Yadong Yuan; Zhaozhong Cheng; Lirong Liang; Huaping Dai; Kewu Huang; Weixuan Lu; Zhonghe Zhang; Xiansheng Cheng; Ying H Shen
Journal:  Respir Res       Date:  2009-12-29

4.  Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.

Authors:  Chen Wang; Zhenguo Zhai; Yuanhua Yang; Qi Wu; Zhaozhong Cheng; Lirong Liang; Huaping Dai; Kewu Huang; Weixuan Lu; Zhonghe Zhang; Xiansheng Cheng; Ying H Shen
Journal:  Chest       Date:  2009-09-09       Impact factor: 9.410
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.